Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

25%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 4Post-market surveillance

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Other(3)

Detailed Status

unknown3

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (50.0%)

N/A1 (50.0%)

Trials by Status

unknown375%

completed125%

Recent Activity

0 active trials

Showing 4 of 4

unknown

Predicative Value of Multimodal MRI in Moyamoya Disease

NCT03785171

unknownnot_applicable

Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery

NCT02305407

completed

Registry of First-line Treatments in Patients With Critical Limb Ischemia

NCT01877252

unknownphase_4

Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial

NCT01810224

Clinical Trials (4)

Showing 4 of 4 trials

NCT03785171

Predicative Value of Multimodal MRI in Moyamoya Disease

Unknown

NCT02305407Not Applicable

Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery

Unknown

NCT01877252

Registry of First-line Treatments in Patients With Critical Limb Ischemia

Completed

NCT01810224Phase 4

Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial

Unknown

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4